Soyfoods and disease prevention: Part I - Coronary heart disease

Agro Food Industry Hi-Tech

Volumn 14, Issue 5, 2003, Pages 7-10

  Messina, Mark ^a,b  

^a Nutrition Matters Inc   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY HEART DISEASE (CHD); SOYFOODS;

BLOOD; BLOOD VESSELS; CARDIOLOGY; CHOLESTEROL; COMPLEXATION; DISEASES; DRUG PRODUCTS; EPIDEMIOLOGY; HEALTH RISKS; HORMONES; NUTRITION; OILS AND FATS; ONCOLOGY; OXIDATION; PROTEINS; TUMORS;

FOOD PRODUCTS;

GLYCINE MAX;

EID: 0345871027     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. United Soybean Board. 10th Annual Consumer Attitudes About Nutrition. 2003-2004 National Report. St. Louis, Missouri: United Soybean Board, 2000
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 2002; 288:321-33
3. Lagro-Janssen T, Rosser WW, van Weel C. Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces. Lancet 2003; 362:414-5
4. Messina M. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 2003; 61:117-131
5. Griffiths K. Estrogens and prostatic disease. International Prostate Health Council Study Group. Prostate 2000; 45:87-100
6. Schaafsma G. The protein digestibility-corrected amino acid score. J Nutr 2000; 130:18655-75
7. Sarwar G, Peace RW, Botting HG. Corrected relative net protein ratio (CRNPR) method based on differences in rat and human requirements for sulfur amino acids. J Am Oil Chem Soc 1985; 68:68:689-693
8. Sarwar G. The protein digestibility-corrected amino acid score method overestimates quality of proteins containing antinutritional factors and of poorly digestible proteins supplemented with limiting amino acids in rats. J Nutr 1997; 127:758-64
9. U.S. Department of Agriculture. Modification of the Vegetable Protein Products Requirements for the National School Lunch Program, School Breakfast Program, Summer Food Service Program and Child and Adult Care Food Program. Federal Register 2000; 7 CFR Parts 210, 215, 220, 225 and 226:12429-12442
10. Kerstetter JE, O'Brien KO, Insogna KL. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 2003; 133:8555-615
11. U.S. Department of Agriculture ARS. USDA Nutrient Database for Standard Reference, Release 13. 1999. Nutrient Data Laboratory Home Page, http://www.nal.usda.gov/fnic/foodcomp
12. Marckmann P. Fishing for heart protection. Am J Clin Nutr 2003; 78:1-2
13. Murphy PA, Song T, Buseman G, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem 1999; 47:2697-704
14. Naciff JM, Jump ML, Torontali SM, et al. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 2002; 68:184-99
15. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effect of phytoestrogen-rich diet on postmenopausal women. Menopause 1997; 4::89-94
16. Arjmandi BH, Smith BJ, Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 2002; 13:130-137
17. Messina M, Gugger ET, Alekel DL. Soy protein, soybean isoflavones, and bone health: a review of the animal and human data. In: Wildman R, ed. Handbook of Nutraceuticals and Functional Foods. Boca Raton: CRC Press LLC, 2001:77-98
18. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA, Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo- controlled study. Menopause 2000; 7:236-42
19. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999; 84:3479-84
20. Anderson JW, Johnstone BM, Cook-Newell ME, Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333:276-82
21. Constantinou A, Huberman E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc Soc Exp Biol Med 1995; 208:109-15
22. Messina M, Messina V. Provisional Recommended Soy Protein and Isoflavone Intakes for Healthy Adults: Rationale. Nutr Today 2003; 38:100-109
23. van Erp-Baart MA, Brants HA, Kiely M, et al. Isoflavone intake in four different European countries: the VENUS approach. Br J Nutr 2003; 89 Suppl 1:S25-30
24. Hodges RE, Krehl WA, Stone DB, Lopez A. Dietary carbohydrates and low cholesterol diets: effects on serum lipids on man. Am J Clin Nutr 1967; 20:198-208
25. Erdman JW, Jr. Control of serum lipids with soy protein. N Engl J Med 1995; 333:313-5
26. Food and Drug Administration. Food labeling, health claims, soy protein, and coronary heart disease. Fed Reg 1999; 57:699-733
27. Erdman JW, Jr. Soy protein and cardiovascular disease: A statement for healthcare professionals from the nutrition committee of the AHA. Circulation 2000; 102:2555-9
28. Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 2003; 57:940-6
29. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. Jama 2003; 290:502-10
30. Messina M. Potential public health implications of the hypocholesterolemic effects of soy protein. Nutr 2003; 19:280-281
31. Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998; 128:209-13
32. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Jr., Hasler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000; 71:1077-84
33. Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002; 76:78-84
34. Manzoni C, Duranti M, Eberini I, et al. Subcellular Localization of Soybean 7S Globulin in HepG2 Cells and LDL Receptor Up-Regulation by Its alpha' Constituent Subunit. J Nutr 2003; 133:2149-55
35. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-65
36. Rivas M, Garay RP, Escanero JF, Cia P, Jr., Cia P, Alda JO. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 2002; 132:1900-2
37. West SG. Blood pressure and vascular effects of soy: how strong is the evidence? Current Topics Nutraceutical Res 2003; 1:17-30
38. Stamler R. Implications of the INTERSALT study. Hypertension 1991; 17:116-20
39. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52:223-61
40. Kanazawa T, Osanai T, Zhang XS, et al. Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases, J Nutr 1995; 125:6395-6465
41. Tikkanen MJ, Adlercreutz H. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem Pharmacol 2000; 60:1-5
42. Wiseman H, O'Reilly JD, Adlercreutz H, et al. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000; 72:395-400
43. Djuric Z, Chen G, Doerge DR, Heilbrun LK, Kucuk O. Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett 2001; 172:1-6
44. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999; 84:895-8
45. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997; 17:3392-8
46. Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003; 23:1066-71
47. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17b- Estradiol. Circulation 2001; 103:258-262
48. Squadrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 2002; 163:339-47
49. Squadrito F, Altavilla D, Crisafulli A, et al. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003; 114:470-6
50. Cuevas AM, Irribarra VL, Castillo OA, Yanez MD, Germain AM. Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women. Eur J Clin Nutr 2003; 57:889-894
51. Zhang X, Shu XO, Gao YT, et al. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 2003; 133:2874-8